Company: INGN
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0000950170-25-066966
Chunk: 4

Company: Inogen Inc
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 2
Chunk 4
---
Forward-Looking Statements

The following discussion and analysis of the financial condition and results of our operations should be in conjunction with the consolidated financial statements and related notes elsewhere in this Quarterly Report on Form 10-Q. This discussion contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, that are based on our management’s beliefs and assumptions and on information currently available to our management. The forward-looking statements are contained principally in this Management’s Discussion and Analysis of Financial Condition and Results of Operations and in the section entitled “Risk Factors” of our Annual Report on Form 10-K and our subsequently filed Quarterly Reports on Form 10-Q filed with the SEC. Forward-looking statements include, but are not limited to, statements concerning the following:

•information concerning our possible or assumed future cash flows, revenue, sources of revenue, results of operations, and operating and other expenses;

•the impact of expense inflation on the components we use in our products, and the impact of inflation of the ability of our customers to afford our products;

•the potential for future supply chain constraints;

•our assessment and expectations regarding reimbursement rates, future rounds of competitive bidding, Centers for Medicare and Medicaid Services changes to Home Use of Oxygen national coverage determination and how those changes are implemented, and future changes in rental revenue;

•our ability to develop new products, improve our existing products, and increase the value of our products;

•our expectations regarding the timing of new products and product improvement launches as well as product features and specifications;

•our expectations with respect to our cost reduction initiatives;

•our expectations regarding regulatory approvals and government and third-party payor coverage and reimbursement;

•the ability of our competitors to introduce products to the market that may be lower priced than ours, may have more product features than ours, or are otherwise more accepted by the market, including our home medical equipment providers;

•our ability to attract key talent to the Company, and to retain key employees;

•our ability to efficiently integrate Physio-Assist and our ability to obtain reimbursement coverage and payment for the Physio-Assist products in the U.S.;

•expectations with respect to market share, unit sales, business strategies, financing plans, expansion of our business, competitive position, industry environment, and potential growth opportunities;

•our expectations regarding the market size, market growth, and the growth potential for our